[1]张 艳,杨勇锋,张红星,等.精神分裂症患者性别差异研究[J].新乡医学院学报,2018,35(9):784-787.[doi:10.7683/xxyxyxb.2018.09.008]
 ZHANG Yan,YANG Yong-feng,ZHANG Hong-xing,et al.Gender differences in patients with schizophrenia[J].Journal of Xinxiang Medical University,2018,35(9):784-787.[doi:10.7683/xxyxyxb.2018.09.008]
点击复制

精神分裂症患者性别差异研究
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
35
期数:
2018年9
页码:
784-787
栏目:
临床研究
出版日期:
2018-09-05

文章信息/Info

Title:
Gender differences in patients with schizophrenia
作者:
张 艳12杨勇锋12张红星13郝可可12张 燕12李文强2赵晶媛1杜云红1张 岱4吕路线12
(1.新乡医学院第二附属医院精神科,河南 新乡 453002;2.河南省生物精神病学重点实验室,河南 新乡 453002;3.新乡医学院心理学院,河南 新乡 453003;4.北京大学第六医院精神科,北京 100191)
Author(s):
ZHANG Yan12YANG Yong-feng12ZHANG Hong-xing13HAO Ke-ke12ZHANG Yan12LI Wen-qiang2ZHAO Jing-yuan1DU Yun-hong1ZHANG Dai 4LYU Lu-xian12
(1.Department of Psychiatry,the Second Affiliated Hospital of Xinxiang Medical University,Xinxiang 453002,Henan Province,China;2.Henan Key Lab of Biological Psychiatry,Xinxiang 453002,Henan Province,China;3.Department of Psychology,Xinxiang Medical University,Xinxiang 453003,Henan Province,China;4.Department of Psychiatry,the Sixth Hospital of Peking University,Beijing 100191,China)
关键词:
精神分裂症肥胖体质量指数血糖三酰甘油性别差异相关性
Keywords:
schizophreniaobesitybody mass indexblood glucosetriglyceridesgender differencescorrelation
分类号:
R749
DOI:
10.7683/xxyxyxb.2018.09.008
文献标志码:
A
摘要:
目的 探讨不同性别精神分裂症患者的体质量指数(BMI)、糖脂代谢及阳性和阴性症状量表(PANSS)评分的差异。方法 选择2009年4月至2010年7月新乡医学院第二附属医院收治的精神分裂症患者243例为研究对象。所有患者分别使用单一抗精神病药物进行治疗,治疗2个月时测患者身高、体质量及血浆空腹血糖(GLU)、三酰甘油(TG)、高密度脂蛋白(HDL)和低密度脂蛋白(LDL)水平,同时采用PANSS评估患者的精神症状。结果 女性患者发病年龄大于男性患者,女性患者的住院次数及血浆GLU、HDL水平高于男性患者,女性患者的阳性因子、兴奋因子及抑郁因子得分显著高于男性患者(P<0.05)。女性患者使用利培酮的比例高于男性患者(P<0.05)。男性和女性患者的认知因子和阴性因子得分、肥胖发生率及BMI比较差异均无统计学意义(P>0.05)。男性患者BMI与血浆TG、HDL、LDL及GLU水平均无相关性(r=0.103、0.022、0.065、0.169,P>0.05);女性患者BMI与血浆TG水平呈正相关(r=0.181,P<0.05),与HDL、LDL及GLU水平无相关性(r=0.002、0.097、0.151,P>0.05)。男性和女性患者的BMI与PANSS总分、阳性因子得分、阴性因子得分、兴奋因子得分、抑郁因子得分和认知因子得分均无相关性(r男性=-0.016、0.067、0.059、0.076、-0.075、-0.015,r女性=-0.053、-0.064、0.008、-0.066、0.084、-0.096;P>0.05)。结论 精神分裂症患者在BMI、肥胖发生率、认知因子得分及阴性因子得分方面不存在性别差异,在发病年龄、住院次数、血浆GLU和HDL水平、阳性因子得分、兴奋因子得分及抑郁因子得分方面存在性别差异,提示临床医师对不同性别的精神分裂症患者的预防、治疗和康复应区别对待。
Abstract:
Objective To investigate differences of the body mass index (BMI),plasma glucose metabolism,plasma lipid metabolism,positive and negative symptom scale (PANSS) score of schizophrenia patients with different genders.Methods A total of 243 schizophrenic patients in the Second Affiliated Hospital of Xinxiang Medical University from April 2009 to July 2010 were selected as subjects.All patients were treated with a single antipsychotic drug for two months.After two months treatment,the height,body mass,plasma fasting blood glucose (GLU),triglyeride (TG),high density lipoprotein (HDL) and low density lipoprotein (LDL) levels of patients were measured,and the PANSS was used to assess the patient′s mental symptoms.Results The age of onset of female patients was significantly later than that of male patients(P<0.05);the frequency of hospitalization and the levels of plasma GLU and HDL in female patients were significantly higher than those in male patients(P<0.05);the scores of positive factor,excitability factor and depression factor of female patients were significantly higher than those of male patients (P<0.05).The proportion of risperidone in female patients was significantly higher than that in male patients (P<0.05).There was no significant difference in the scores of cognitive factors and negative factors,incidence of obesity and BMI between male and female patients (P>0.05).There was no correlation between BMI and plasma TG,HDL,LDL and GLU levels in male patients (r=0.103,0.022,0.065,0.169;P>0.05).The BMI was positive correlated with plasma TG levels in female patients (r=0.181,P<0.05) and was not correlated with plasma HDL,LDL and GLU levels (r=0.002,0.097,0.151;P>0.05).There was no correlation between BMI and PANSS scores,positive factor scores,negative factor scores,excitatory factor scores,depression factor scores and cognitive factor scores in male and female patients (rmale=-0.016,0.067,0.059,0.076,-0.075,-0.015;rfemale=-0.053,-0.064,0.008,-0.066,0.084,-0.096;P>0.05).Conclusion There is no gender difference in BMI,obesity,in-ward frequency,cognitive factor scores and negative factor scores in patients with schizophrenia;there is gender difference in age of onset,GLU and HDL levels,positive factor score,excitatory factor score and depression factor score.

参考文献/References:

[1] LI Q,DU X,ZHANG Y,et al.The prevalence,risk factors and clinical correlates of obesity in Chinese patients with schizophrenia[J].Psychiatry Res,2017,251:131-136.
[2] RIETSCHEL L,LAMBERT M,KAROW A,et al.Clinical high risk for psychosis:gender differences in symptoms and social functioning[J].Early Interv Psychiatry,2017,11(4):306-313.
[3] GOLDSTEIN J M,CHERKERZIAN S,TSUANG M T,et al.Sex differences in the genetic risk for schizophrenia:history of the evidence for sex-specific and sex-dependent effects[J].Am J Med Genet B Neuropsychiatr Genet,2013,162B(7):698-710.
[4] HUANG Y C,HUNG C F,LIN P Y,et al.Gender differences in susceptibility to schizophrenia:potential implication of neurosteroids[J].Psychoneuroendocrinology,2017,84:87-93.
[5] 杜云红,吕惠娟.二甲双胍联合行为干预对奥氮平所致精神分裂症患者体质量增加及糖脂代谢紊乱的影响[J].新乡医学院学报,2014,31(5):381-384.
[6] LI Q,CHEN D,LIU T,et al.Sex differences in body mass index and obesity in Chinese patients with chronic schizophrenia[J].J Clin Psychopharmacol,2016,36(6):643-648.
[7] OCHOA S,USALL J,COBO J,et al.Gender differences in schizophrenia and first-episode psychosis:a comprehensive literature review[J].Schizophr Res Treatment,2012,2012:916198.
[8] GARDNER D M,MURPHY A L,O′DONNELL H,et al.International consensus study of antipsychotic dosing[J].Am J Psychiatry,2010,167(6):686-693.
[9] ABORAYA A,NASRALLAH H A.Perspectives on the positive and negative syndrome scale (PANSS):use,misuse,drawbacks,and a new alternative for schizophrenia research[J].Ann Clin Psychiatry,2016,28(2):125-131.
[10] WALLWORK R S,FORTGANG R,HASHIMOTO R,et al.Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia[J].Schizophr Res,2012,137(1/2/3):246-250.
[11] JI C Y,CHEN T J.Empirical changes in the prevalence of overweight and obesity among Chinese students from 1985 to 2010 and corresponding preventive strategies[J].Biomed Environ Sci,2013,26(1):1-12.
[12] 刘旭恩,沈姣,张美霞.阿立哌唑联合无抽搐电休克治疗女性难治性精神分裂症疗效观察[J].新乡医学院学报,2017,34(9):847-850.
[13] 黄飞,姜祥智.青岛地区非自愿住院精神分裂症病人临床特征的性别差异[J].齐鲁医学杂志,2017,32(3):331-333.
[14] 张杰,薛士健,周燕玲,等.精神分裂症患者临床特征的性别差异[J].四川精神卫生,2015,28(4):299-302.
[15] 胡春水,李君,田源,等.长期住院对慢性精神分裂症患者认知功能的影响[J].中国医药导报,2017,14(8):60-63.
[16] LAM B Y,RAINE A,LEE T M.The relationship between neurocognition and symptomatology in people with schizophrenia:social cognition as the mediator[J].BMC Psychiatry,2014,14:138-147.
[17] ZHANG X Y,LIANG J,CHEN D C,et al.Cigarette smoking in male patients with chronic schizophrenia in a Chinese population:prevalence and relationship to clinical phenotypes[J].PLoS One,2012,7(2):e30937.
[18] DAVIS S R,CASTELO-BRANCO C,CHEDRAUI P,et al.Understanding weight gain at menopause[J].Climacteric,2012,15(5):419-429.
[19] XU Y,WANG F.Built environment and obesity by urbanicity in the U.S[J].Health Place,2015,34:19-29.
[20] 徐海冬,桑艳梅,闫洁,等.脂肪含量和肥胖相关基因与中国儿童肥胖病遗传发病机制的相关性[J].中华实用儿科临床杂志,2013,28(20):1544-1547.

相似文献/References:

[1]黄远学,王长虹,苏秀芝,等.77例出院后精神分裂症患者心理调查分析[J].新乡医学院学报,1994,11(03):227.
[2]娄百玉,石玉中,韩巍巍,等.未婚女精神分裂症患者父母的心理分析 [J].新乡医学院学报,1994,11(04):375.
[3]郭素芹,吕路线,郭云,等.一次量氯氮平对精神分裂症患者脑电活动的影响[J].新乡医学院学报,1997,14(02):122.
[4]宋晓敏 杨 冰 杜 玮 郭长磊 李根旺 邬玉芳 郭丽萍.豆番粉与玉米粉对人体血糖胰岛素胰升血糖素的影响[J].新乡医学院学报,1998,15(03):234.
[5]查彩慧 郭国庆.氯丙嗪氯氮平合用治疗精神分裂症临床疗效评价[J].新乡医学院学报,1999,16(04):311.
[6]郭慧荣,张绍荣. 孙富根.利培酮与氯氮平治疗精神分裂症的临床对照研究[J].新乡医学院学报,2001,18(03):174.
[7]李彩霞,张钰,何艳.冬季和夏季出生的精神分裂患者的临床差异[J].新乡医学院学报,2001,18(05):348.
[8]杜云红,郝以辉,王新友.儿童期精神分裂症预后的影响因素分析[J].新乡医学院学报,2001,18(01):058.
[9]扬世昌,祁富生,张疆丽.利培酮治疗精神分裂症2O例[J].新乡医学院学报,2002,19(02):113.
[10]王长虹,李 晏,贾福军,等.工、Ⅱ型精神分裂症患者血清免疫指标的对照分析[J].新乡医学院学报,2002,19(05):360.

更新日期/Last Update: 2018-09-05